Status:
RECRUITING
Triamcinolone Ketorolac (TriKe) Knee Trial
Lead Sponsor:
United Health Services Hospitals, Inc.
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
Cortisone injections are commonly used in the treatment of osteoarthrosis of the knee, but there are known detriments to cortisone including localized tissue atrophy near the injection site and accele...
Detailed Description
Charts will be prescreened for diagnosis or suspicion of osteoarthritis of the knee by the study staff. Those charts identified will be flagged for possible inclusion in the study. The receptionist wi...
Eligibility Criteria
Inclusion
- Knee pain with diagnosis of osteoarthritis/osteoarthrosis
- Weight-bearing x-rays within the last year adequate to assess Kellgran-Lawrence OA stage
- Age \> 21
- English proficiency sufficient to complete surveys
- Willing to complete follow-up surveys
Exclusion
- Prior knee injection in last 3 months
- Knee surgery within the last year
- Contraindications to Cortisone, Ketorolac, or local anesthetic
- Uncontrolled diabetes
- Systemic steroid use in last 3 months
- BMI \> 50
- Non-ambulatory
- Known kidney disease
- Current opioid use
Key Trial Info
Start Date :
September 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05336968
Start Date
September 15 2022
End Date
December 31 2025
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
United Health Services Sports Medicine Department
Vestal, New York, United States, 13850